Global Hypercalcemia Treatment Industry on the Rise, Set to Reach US$55.07 Billion by 2033 with 11.8
The Global Hypercalcemia Treatment Industry is on a resolute trajectory, with a predicted valuation of US$ 18.07 billion by the close of 2023. An impressive Compound Annual Growth Rate (CAGR) of 11.8% underpins this forecast. This steady ascent indicates that the market could surge to an impressive US$ 55.07 billion...